Omnipeptin
| Internal ID | 28e677ba-d46f-4aa6-b7d9-c1e635ca6afa |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (4R)-4-[[(2S)-2-[[(2S)-2-[[(3S)-3-amino-3-carboxypropanoyl]amino]-3-hydroxy-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-[[(2S)-1-[[(3S,6R,9S,12S,15S,19S)-12-(1-amino-1-oxopropan-2-yl)-3-benzyl-9-[(6-chloro-1H-indol-3-yl)methyl]-20-hydroxy-21-methyl-2,5,8,11,14,18-hexaoxo-6-propan-2-yl-17-oxa-1,4,7,10,13-pentazabicyclo[17.3.0]docosan-15-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C64H82ClN13O22/c1-27(2)46-58(92)71-41(19-31-9-7-6-8-10-31)62(96)78-24-28(3)51(85)50(78)64(99)100-26-43(57(91)76-47(29(4)53(67)87)59(93)70-40(55(89)75-46)20-33-23-68-39-21-34(65)13-16-36(33)39)73-60(94)48(30(5)80)77-54(88)38(17-18-45(83)84)69-56(90)42(25-79)72-61(95)49(74-44(82)22-37(66)63(97)98)52(86)32-11-14-35(81)15-12-32/h6-16,21,23,27-30,37-38,40-43,46-52,68,79-81,85-86H,17-20,22,24-26,66H2,1-5H3,(H2,67,87)(H,69,90)(H,70,93)(H,71,92)(H,72,95)(H,73,94)(H,74,82)(H,75,89)(H,76,91)(H,77,88)(H,83,84)(H,97,98)/t28?,29?,30?,37-,38+,40-,41-,42-,43-,46+,47-,48-,49-,50-,51?,52?/m0/s1 |
| InChI Key | TVZYKKNRWFVGID-XMQDSMCMSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C64H82ClN13O22 |
| Molecular Weight | 1420.90 g/mol |
| Exact Mass | 1419.5385890 g/mol |
| Topological Polar Surface Area (TPSA) | 569.00 Ų |
| XlogP | -4.50 |
| Atomic LogP (AlogP) | -5.01 |
| H-Bond Acceptor | 21 |
| H-Bond Donor | 19 |
| Rotatable Bonds | 26 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9024 | 90.24% |
| Caco-2 | - | 0.8638 | 86.38% |
| Blood Brain Barrier | - | 0.8750 | 87.50% |
| Human oral bioavailability | - | 0.5429 | 54.29% |
| Subcellular localzation | Lysosomes | 0.5646 | 56.46% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8086 | 80.86% |
| OATP1B3 inhibitior | + | 0.9328 | 93.28% |
| MATE1 inhibitior | - | 0.7609 | 76.09% |
| OCT2 inhibitior | - | 0.8500 | 85.00% |
| BSEP inhibitior | + | 0.9462 | 94.62% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8658 | 86.58% |
| CYP3A4 substrate | + | 0.7593 | 75.93% |
| CYP2C9 substrate | - | 0.7975 | 79.75% |
| CYP2D6 substrate | - | 0.8162 | 81.62% |
| CYP3A4 inhibition | - | 0.6050 | 60.50% |
| CYP2C9 inhibition | - | 0.8190 | 81.90% |
| CYP2C19 inhibition | - | 0.7598 | 75.98% |
| CYP2D6 inhibition | - | 0.8274 | 82.74% |
| CYP1A2 inhibition | - | 0.8770 | 87.70% |
| CYP2C8 inhibition | + | 0.8234 | 82.34% |
| CYP inhibitory promiscuity | - | 0.5815 | 58.15% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.6800 | 68.00% |
| Carcinogenicity (trinary) | Non-required | 0.4925 | 49.25% |
| Eye corrosion | - | 0.9862 | 98.62% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7749 | 77.49% |
| Skin corrosion | - | 0.9295 | 92.95% |
| Ames mutagenesis | - | 0.6937 | 69.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7243 | 72.43% |
| Micronuclear | + | 0.9100 | 91.00% |
| Hepatotoxicity | - | 0.5791 | 57.91% |
| skin sensitisation | - | 0.8650 | 86.50% |
| Respiratory toxicity | + | 0.8778 | 87.78% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | + | 0.4764 | 47.64% |
| Acute Oral Toxicity (c) | III | 0.5362 | 53.62% |
| Estrogen receptor binding | + | 0.5720 | 57.20% |
| Androgen receptor binding | + | 0.7263 | 72.63% |
| Thyroid receptor binding | + | 0.7483 | 74.83% |
| Glucocorticoid receptor binding | + | 0.7890 | 78.90% |
| Aromatase binding | + | 0.7679 | 76.79% |
| PPAR gamma | + | 0.7719 | 77.19% |
| Honey bee toxicity | - | 0.6305 | 63.05% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5600 | 56.00% |
| Fish aquatic toxicity | + | 0.8823 | 88.23% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.95% | 98.95% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.74% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.83% | 96.09% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 97.93% | 83.82% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 96.75% | 96.11% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 96.72% | 97.31% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 96.64% | 99.15% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.54% | 95.56% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.37% | 90.08% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.32% | 97.09% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.82% | 93.10% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 95.59% | 94.45% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 95.32% | 97.23% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 95.03% | 91.71% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.85% | 94.45% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 94.60% | 82.86% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 94.06% | 88.42% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.90% | 97.64% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 93.83% | 95.38% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 93.33% | 99.17% |
| CHEMBL204 | P00734 | Thrombin | 93.21% | 96.01% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.05% | 97.14% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 91.73% | 95.00% |
| CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 91.49% | 98.33% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 91.07% | 85.14% |
| CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 90.97% | 100.00% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 90.34% | 92.29% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 90.26% | 89.00% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 90.25% | 96.28% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 89.66% | 89.50% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 89.53% | 88.10% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.28% | 95.89% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 88.60% | 98.05% |
| CHEMBL3837 | P07711 | Cathepsin L | 88.19% | 96.61% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.44% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.33% | 96.47% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 86.93% | 95.56% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 86.91% | 91.19% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 86.83% | 90.20% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 86.61% | 88.56% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 86.46% | 94.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.89% | 96.90% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 85.57% | 98.33% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 85.55% | 85.00% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 85.51% | 99.23% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 83.93% | 95.50% |
| CHEMBL236 | P41143 | Delta opioid receptor | 83.42% | 99.35% |
| CHEMBL2535 | P11166 | Glucose transporter | 83.15% | 98.75% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.25% | 95.89% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 81.68% | 96.37% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 81.56% | 90.00% |
| CHEMBL3776 | Q14790 | Caspase-8 | 81.20% | 97.06% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 81.00% | 96.61% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 80.88% | 94.75% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 80.81% | 92.32% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 80.68% | 93.18% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 80.29% | 90.71% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.21% | 96.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683589 |
| LOTUS | LTS0201534 |
| wikiData | Q105265672 |